Mdxhealth Sa Adr Stock Alpha and Beta Analysis

MDXH Stock  USD 2.88  0.02  0.70%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as MDxHealth SA ADR. It also helps investors analyze the systematic and unsystematic risks associated with investing in MDxHealth over a specified time horizon. Remember, high MDxHealth's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to MDxHealth's market risk premium analysis include:
Beta
(0.22)
Alpha
(0.23)
Risk
4.56
Sharpe Ratio
(0.04)
Expected Return
(0.20)
Please note that although MDxHealth alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, MDxHealth did 0.23  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of MDxHealth SA ADR stock's relative risk over its benchmark. MDxHealth SA ADR has a beta of 0.22  . As returns on the market increase, returns on owning MDxHealth are expected to decrease at a much lower rate. During the bear market, MDxHealth is likely to outperform the market. As of now, MDxHealth's Price Fair Value is increasing as compared to previous years. The MDxHealth's current Enterprise Value is estimated to increase to about 127 M, while Book Value Per Share is projected to decrease to 0.26.

Enterprise Value

127.02 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out MDxHealth Backtesting, MDxHealth Valuation, MDxHealth Correlation, MDxHealth Hype Analysis, MDxHealth Volatility, MDxHealth History and analyze MDxHealth Performance.

MDxHealth Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. MDxHealth market risk premium is the additional return an investor will receive from holding MDxHealth long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in MDxHealth. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate MDxHealth's performance over market.
α-0.23   β-0.22

MDxHealth expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of MDxHealth's Buy-and-hold return. Our buy-and-hold chart shows how MDxHealth performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

MDxHealth Market Price Analysis

Market price analysis indicators help investors to evaluate how MDxHealth stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MDxHealth shares will generate the highest return on investment. By understating and applying MDxHealth stock market price indicators, traders can identify MDxHealth position entry and exit signals to maximize returns.

MDxHealth Return and Market Media

The median price of MDxHealth for the period between Mon, Feb 19, 2024 and Sun, May 19, 2024 is 2.82 with a coefficient of variation of 16.36. The daily time series for the period is distributed with a sample standard deviation of 0.47, arithmetic mean of 2.88, and mean deviation of 0.39. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Agiliti Q4 Earnings Beat Estimates
03/05/2024
2
MDxHealth SA Q4 2023 Earnings Call Transcript
03/07/2024
3
Piper Sandler Increases MDxHealth Price Target to 7.00
03/11/2024
4
MDxHealth expands prostate cancer test portfolio
03/12/2024
5
AMN Healthcare Services Surpasses Q1 Earnings and Revenue Estimates - Yahoo Lifestyle UK
04/18/2024
6
Elevance to Divest Life Disability Business to StanCorp - Yahoo Movies Canada
05/02/2024
7
Mdxhealth to Present at Upcoming Investor Conferences
05/15/2024

About MDxHealth Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including MDxHealth or other stocks. Alpha measures the amount that position in MDxHealth SA ADR has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding83.192.1758.6155.68
PTB Ratio2.4811.2614.1614.87

MDxHealth Upcoming Company Events

As portrayed in its financial statements, the presentation of MDxHealth's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MDxHealth's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of MDxHealth's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of MDxHealth. Please utilize our Beneish M Score to check the likelihood of MDxHealth's management manipulating its earnings.
13th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with MDxHealth

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether MDxHealth SA ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MDxHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mdxhealth Sa Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mdxhealth Sa Adr Stock:
Check out MDxHealth Backtesting, MDxHealth Valuation, MDxHealth Correlation, MDxHealth Hype Analysis, MDxHealth Volatility, MDxHealth History and analyze MDxHealth Performance.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for MDxHealth Stock analysis

When running MDxHealth's price analysis, check to measure MDxHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MDxHealth is operating at the current time. Most of MDxHealth's value examination focuses on studying past and present price action to predict the probability of MDxHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MDxHealth's price. Additionally, you may evaluate how the addition of MDxHealth to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
MDxHealth technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of MDxHealth technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of MDxHealth trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...